Thelma Therapeutics (XKRX:015540) Other Net Income (Loss) : ₩-69 Mil (TTM As of Sep. 2022)

View and export this data going back to 1989. Start your Free Trial

What is Thelma Therapeutics Other Net Income (Loss)?

Thelma Therapeutics's Other Net Income (Loss) for the three months ended in Sep. 2022 was ₩0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2022 was ₩-69 Mil.

Thelma Therapeutics's annual Other Net Income (Loss) declined from Dec. 2019 (₩0 Mil) to Dec. 2020 (₩-4,799 Mil) but then increased from Dec. 2020 (₩-4,799 Mil) to Dec. 2021 (₩-64 Mil).

Thelma Therapeutics Other Net Income (Loss) Historical Data

The historical data trend for Thelma Therapeutics's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thelma Therapeutics Other Net Income (Loss) Chart

Thelma Therapeutics Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Other Net Income (Loss)

Get a 7-Day Free Trial

171.97

-4,799.32

-64.47

Thelma Therapeutics Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-69.36	-	-	-

Thelma Therapeutics Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-69 Mil.

Thelma Therapeutics Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Thelma Therapeutics's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Thelma Therapeutics (XKRX:015540) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Thelma Therapeutics (XKRX:015540) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Mapo-gu, Seoul Sangam DMC Prugio City, 25, World Cup Buk-ro 54-gil, Seoul, KOR

Website

http://www.medi-plant.co.kr

Thelma Therapeutics, formerly Medipartner Biotechnology is a South Korean company engaged in providing hospital management support, dental material distribution, medical devices manufacturing, and development of new materials.

Thelma Therapeutics (XKRX:015540) Headlines

No Headlines